The value of noninvasive measurements in hypertension
Article Abstract:
Although people with high blood pressure (hypertension) are at increased risk for cardiovascular disease, many do not develop it. Within a group of individuals with similarly elevated blood pressure, some are at higher risk for cardiovascular disease than others; identification of these persons has not proved easy. One measurement known to be correlated with increased risk is left ventricular (LV) hypertrophy (enlargement of the left ventricle, the chamber of the heart that pumps blood to the body). LV mass can be measured noninvasively with echocardiography, which uses ultrasound. The relationship between LV mass and cardiovascular disease is so consistent that other physiological abnormalities found to be correlated with LV mass are investigated for their predictive values. Such is the case with the glomerular filtration rate (the rate at which the kidneys filter the blood), as shown in an article in the December 5, 1990 issue of The Journal of the American Medical Association. The investigators found that patients with increased glomerular filtration rates also had increased LV mass. It was proposed that glomerular hyperfiltration is a sign of early vascular disease from hypertension. The limitations of LV mass measurement as an indicator of damage due to hypertension are discussed. Although it is clearly helpful in deciding whether patients with borderline hypertension require medication, an effect of antihypertensive treatment on LV mass has not been reliably demonstrated. Repeated measurements on patients under treatment, therefore, do not yield useful information about treatment effectiveness. Finally, hypertension is increasingly being viewed as a cardiovascular disease in and of itself. (Consumer Summary produced by Reliance Medical Information, Inc.)
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1990
User Contributions:
Comment about this article or add new information about this topic:
Antihypertensive therapy: to stop or not to stop?
Article Abstract:
Patients with moderate or severe hypertension (high blood pressure) who take antihypertensive drugs have fewer cardiovascular (heart and circulatory system) complications, and patients with mild hypertension have almost 40 percent fewer strokes and 9 percent fewer heart attacks when their blood pressure is lowered. Yet there is considerable controversy about treating mild hypertension because the side effects are sometimes worse than the effects of hypertension, and the benefits are limited. The side effects, including impotence, digestive and sleep disorders, dizziness, nausea, and others, cause many patients to stop taking their medication. Metabolic disorders caused by these drugs sometimes more than offset the benefit of lower blood pressure. Intermittent therapy or even discontinuation would be useful in preventing overtreatment and minimizing the metabolic side effects of the drugs. Studies of discontinuation of antihypertensive medication have reported varying success rates. The success rates are evaluated, and the physiological rationale for intermittent therapy is discussed. In one study, patients who were the most likely to be successful in maintaining a normal blood pressure were normal-weight and mildly hypertensive, and followed nutritional guidelines. Those who received nutritional therapy for weight loss also did well. Approximately 10 percent of essential hypertension is caused by moderate to heavy drinking, therefore restriction of alcohol intake may be a good indication of whether step-down or discontinuance of medication with be successful. Discontinuance of drug therapy is safe, provided that blood pressure is monitored afterward. (Consumer Summary produced by Reliance Medical Information, Inc.)
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1991
User Contributions:
Comment about this article or add new information about this topic:
Glomerular hyperfiltration indicates early target organ damage in essential hypertension
Article Abstract:
One consequence of hypertension (high blood pressure) can be kidney damage, and identification of kidney disease (nephropathy) in its earliest stages is highly desirable. The glomerular filtration rate, the rate at which fluid is filtered by the glomeruli (small structures in the kidney through which fluid passes on its way to becoming urine), may be such an indicator. Increases in the rate (hyperfiltration) are known to precede the development of some kidney diseases. To evaluate whether glomerular filtration rate could be a good predictor of nephropathy, 111 patients with mild to moderate hypertension (diastolic blood pressure consistently higher than 90 mm Hg after resting) were studied. Patients underwent echocardiography (ultrasound examination of the heart) to measure the chambers of their hearts; certain findings are known to be correlated with the risk of vascular disease in hypertensive patients. In 52 patients, invasive studies were performed to evaluate kidney function. Results showed a significant correlation between glomerular filtration rate and the mass and cross-sectional area of the left ventricle (the chamber of the heart that pumps blood to the body). Patients with left ventricular hypertrophy (enlargement) had higher glomerular filtration rates than patients who did not have ventricular hypertrophy. The patients had normal kidney function. Whether glomerular hyperfiltration is an early stage of nephropathy remains to be determined; however, it appears to be related to at least one other variable (left ventricular hypertrophy) that is associated with structural change in hypertensive patients. (Consumer Summary produced by Reliance Medical Information, Inc.)
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1990
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: The effects of antihypertensive therapy on left ventricular mass in elderly patients. Reversing cardiac hypertrophy in hypertension
- Abstracts: The role of timing in high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia
- Abstracts: Pregnancy-induced hypertension and low birth weight: the role of calcium. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations
- Abstracts: A formal audit of continuing medical education activity for license renewal. Continuing medical education at a crossroads
- Abstracts: The efficacy of lithium in prophylaxis of unipolar depression: evidence from its discontinuation. Lithium augmentation in antidepressant-resistant patients: a quantitative analysis